64, and 38 to 75 U/liter, respectively. Activities of sera from 15 patients with acute myocardial infarction (total lactate dehydrogenase) ranged from 212 to 800 U/liter and lactate dehydrogenase isoenzymes 1 and 2 ranged from 138 to 628 U/liter. Lactate dehydrogenase and creatine kinase isoenzymes were rapidly and easily measured after being simultaneously separated. The procedure is specific and sensitive for following the post-infarct time course of changes in isoenzyme activities.
Previously, I described a column chromatographic technique for separating serum creatine kinase (CK)1 isoenzymes (1). CK isoenzymes MM, MB, and BB were isolated by ion-exchange chromatography on mini-columns containing DEAE-Sephadex; column effluents were quantified with an assay normally used to determine total serum CK. Recently, the clinical usefulness of this technique in diagnosis of myocardial infarction has been demonstrated by several investigators (2-4). Lactate dehydrogenase (LD), like CK, is a diagnostically useful enzyme for detecting and monitoring myocardial necrosis. Although LD is an ubiquitous enzyme, the ability to measure the activities of its isoenzymes in serum has greatly improved the clinical usefulness of such measurements
(5).
I describe here a partial separation of serum LD isoenzymes with the previously described CK ionexchange column technique (1).LD isoenzymes 1 and 2 are separated from LD isoenzymes 3, 4, and 5, and column effluents are quantitatively assayed with a conventional serum LD procedure. This columnchromatographic technique for simultaneously assessing CK and LD isoenzymes is evaluated with respect to sera from healthy individuals and from patients with recent myocardial infarction. were reconstituted with water as specified by the manufacturer. The ABA-100 print-out for total CK (calibration factor, 1130) was in U/liter; the print-out for columnfractionated LD isoenzymes (calibration factor, 6000) was converted to U/liter as follows. A reference sample with known LD activity was assayed in the same manner as the column effluents. A conversion factor was calculated: Factor = LD, U/liter (reference)! print-out (reference).This factor was then used in the following formula to convert the ABA-100 printout (i.e., the raw data) to U/liter. Print-out (column effluents) X factor = LD, U/liter. LD activity was linearly related to print-out to 1700 U/liter. Routinely, only fractions 1, 2, 3, 7, 8, and 9 were assayed for LD. CK isoenzymes MM and MB in column effluents were assayed with the ABA-100 as previously described (9).
Column Chromatography
One milliliter of serum was applied to a mini-column of DEAE-Sephadex A-SO as described by Mercer (1). The modified elution scheme of Mercer and Varat (9) (five 1-ml fractions of 100 mmol/liter sodium chloride and three 1-ml fractions of 200 mmol/ liter sodium chloride) was used to simultaneously separate MM, MB, LD-3,4,5, and LD-.1,2 isoenzymes.
LD isoenzyme electrophoresis was performed on polyacrylamide (70 g/liter) with an analytical vertical-gel apparatus (Ames Co., Elkhart, md. 46514). Samples diluted with an equal volume of sucrose (400 g/liter) were applied to the top of the polymerized gel (0.5 X 3.5 cm) and electrophoresed at 2 mA per gel with the Tris-glycine buffer system as originally described by Davis (JO). LD isoenzymes were detected by the staining technique of Dietz and Lubrano (11).
Results
The ion-exchange chromatographic system was characterized by chromatographing extracts of CKand LD-rich tissues. Figure 1 Electrophoretic identification of column-fractionated LD is shown in Figure 2 . In this experiment, aliquots of effluent fractions 1-9 of skeletal muscle, liver, and heart extracts from DEAE-Sephadex col- umns were applied to polyacrylamide gels. Electrophoresis and subsequent LD staining revealed LD isoenzymes 1 and 2 in fractions 7 to 9 and LD isoenzymes 3, 4, and 5 to be prominent in fractions 1 to 3. Figure 3 shows the total activity for LD and CK in each fraction of effluent, for a patient 48 h after onset of an acute myocardial infarction. LD activity is predominant in fractions 7-9 (LD-1,2). Significant amounts of MB-CK activity were also evident in fractions 7-9. For healthy individuals, CK and MB-CK activities similar to those previously described for normal individuals were observed (9). There were nearly equal amounts of LD activity in effluent fractions 7-9 (LD-1,2) and 1-3 (LD-3,4,S). Table 2 summarizes results for MB-CK, LD-1,2, and LD-3,4,5 in sera of Recovery of total LD was <100% because LD activity in column fractions 4, 5, and 6 was not included in the recovery calculation. Figure 4 shows typical changes in post-infarct activities of MB-CK and LD-1,2 with time. MB-CK activity was greatest at 24 h, followed by a sharp decline to base values at 72 h. In contrast, LD-1,2 increased slowly to a maximum at 72 h, followed by a slow decline. LD-3,4,5 remained within normal limits in uncomplicated cases of myocardial infarction but patients with progressive congestive failure had abnormally high values.
Column reproducibility for LD-1,2 was demonstrated by daily analysis of an abnormal pool collect- total LD were usually in the 97 to 132% range when all nine column fractions were assayed. Column capacity for LD isoenzymes was not exceeded when samples with LD activity as great as 3000 U/liter were applied to the column.
Discussion
Measurement of LD isoenzymes has greatly improved the clinical usefulness of LD, especially in diagnosis of cardiac and hepatic disease (5, 12 and assays per day, with report forms usually being returned to the patient's chart within 8 h of sample collection.
The incomplete separation of LD isoenzymes by this procedure does not appear to impair its usefulness (Tables 1, 2 and Figures 3, 4) . Moreover, because combined LD and CK isoenzyme analysis is easily performed, the procedure enhances patient monitoring, especially in suspected cases of myocardial infarction.
There is evidence elsewhere (21) for the clinical usefulness of combined LD and CK isoenzyme determinations, and this is borne out by comparing timecourse curves produced by the present technique ( Figure 5) Clin. Chem. 20,36 (1974 CIin. Chem. 21,381 (1975 
